David Gionco, Chief Accounting Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 47,876 shares at $0.08 ($4K) on 2013-10-15, disclosed to the SEC on 2013-10-17.
Open-market sale of $4k SVNT by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.08 | 3,000 | $240 | 6.3% |
| 2 | $0.08 | 5,476 | $438 | 11.4% |
| 3 | $0.08 | 8,500 | $680 | 17.8% |
| 4 | $0.08 | 10,000 | $800 | 20.9% |
| 5 | $0.08 | 20,900 | $2K | 43.7% |
| Total | $0.08 avg | 47,876 |
| $4K |
| 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |